Difference between revisions of "Actinium Ac 225 lintuzumab (Actimab-A)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Intravenous chemotherapy" to "Category:Intravenous medications") |
m |
||
(10 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | =Mechanism of action= | + | ==Mechanism of action== |
Monoclonal antibody directed against CD33 with a radioactive agent attached. | Monoclonal antibody directed against CD33 with a radioactive agent attached. | ||
− | =Preliminary data= | + | ==Preliminary data== |
− | ==[[Acute myeloid leukemia]]== | + | ===[[Acute myeloid leukemia]]=== |
− | + | ==Also known as== | |
− | [[Category: | + | *'''Brand name:''' Actimab-A |
+ | |||
+ | [[Category:Drugs]] | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
− | [[Category: | + | [[Category:Radiotherapy medications]] |
− | + | [[Category:Anti-CD33 radioimmunoconjugates]] | |
− | [[Category:Anti-CD33 | ||
− | [[Category:Acute myeloid leukemia medications]] | + | [[Category:Acute myeloid leukemia medications (investigational)]] |
− | [[Category:Investigational]] | + | [[Category:Investigational drugs]] |
Latest revision as of 21:05, 30 June 2023
Mechanism of action
Monoclonal antibody directed against CD33 with a radioactive agent attached.
Preliminary data
Acute myeloid leukemia
Also known as
- Brand name: Actimab-A